ArticleGlobal bioethics = Problemi di bioetica2018
Quality of medicines in resource-limited settings: need for ethical guidance.
Article in Global bioethics = Problemi di bioetica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Pharmaceutical quality and cost-effectiveness of branded versus generic medicines across 22 drug types and 8 therapeutic categories: a citizen-funded comparative study from regulated retail outlets in Kerala, India.Frontiers in pharmacology · 2026Article
- Packaging, Labeling, and Physical Characteristics and Sales Volume Assessment of Veterinary Antimicrobials in a Resource-Limited Setting: Evidence From Hawassa Town, Ethiopia.Veterinary medicine international · 2026Article
- Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity.PLOS global public health · 2026Article
- Lessons from Ethiopian pharmaceutical regulation: a risk-based approach to overcome challenges and unlock opportunities.Frontiers in medicine · 2025Article
- Challenges of Antibiotic Formulations and Administration in the Treatment of Bloodstream Infections in Children Under Five Admitted to Kisantu Hospital, Democratic Republic of Congo.The American journal of tropical medicine and hygiene · 2023Article
- Uncertainties about the quality of medical products globally: lessons from multidisciplinary research.BMJ global health · 2023Article
- Situation analysis on the regulation of nanomedicines in Southern Africa.Frontiers in medicine · 2023Article
- How the concept of WHO-listed authorities will change international procurement policies for medicines.BMJ global health · 2022Article
- A comprehensive analysis of selected medicines collected from private drug outlets of Dhaka city, Bangladesh in a simple random survey.Scientific reports · 2022Article
- "Global bioethics = Problemi di bioetica · 2022Article
- Assessment of blood cultures and antibiotic susceptibility testing for bacterial sepsis diagnosis and utilization of results by clinicians in Benin: A qualitative study.Frontiers in public health · 2022Article
- Elusive quality: the challenges and ethical dilemmas faced by international non-governmental organisations in sourcing quality assured medical products.BMJ global health · 2021Review
- Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites.BMC pharmacology & toxicology · 2021Article
- Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward.BMJ global health · 2020Article
- A survey of nongovernmental organizations on their use of WHO's prequalification programme.Bulletin of the World Health Organization · 2020Article
- The importance of visual inspection in national quality assurance systems for medicines.Journal of pharmaceutical policy and practice · 2020Article
- A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines.Journal of pharmaceutical policy and practice · 2020Article
- Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage.Journal of pharmaceutical policy and practice · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The quality of medicines is generally adequately assured by manufacturers and regulatory authorities for well-resourced settings, while the implementation of existing quality standards is challenged in many low- and middle-income countries. This situation of multiple pharmaceutical standards raises the question whether it could ever be ethically justified to compromise on the quality assurance of medicines depending on what individuals, communities, or societies can afford. In this paper, we contend that ethically, any unjustified exceptions to medicines' quality assurance represents a violation of the principles of beneficence and non-maleficence. Exceptions are only acceptable in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.